Inside Drug Pricing

Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.

House GOP Optimistic On Finance Rx Pricing Bill, But Won’t Endorse

Key GOP House members are signaling cautious support for the Senate Finance Committee’s bipartisan drug pricing plan after a meeting between HHS Secretary Alex Azar, House Republicans and Senate Finance Chair Chuck Grassley (R-IA) on Thursday (Sept. 19).

form.antibot { display: none !important; } You must have JavaScript enabled to use this form.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.

Login

Inside Drug Pricing

House GOP Optimistic On Finance Rx Pricing Bill, But Won’t Endorse

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.